Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$2.48 - $5.22 $7,440 - $15,660
-3,000 Reduced 4.75%
60,125 $279,000
Q4 2022

Feb 13, 2023

BUY
$1.75 - $3.96 $9,703 - $21,958
5,545 Added 9.63%
63,125 $142,000
Q2 2022

Aug 02, 2022

BUY
$1.92 - $6.28 $15,360 - $50,240
8,000 Added 16.14%
57,580 $158,000
Q1 2022

May 06, 2022

BUY
$5.07 - $7.2 $10,140 - $14,400
2,000 Added 4.2%
49,580 $298,000
Q4 2021

Feb 03, 2022

BUY
$5.67 - $8.54 $21,262 - $32,024
3,750 Added 8.56%
47,580 $306,000
Q3 2021

Nov 03, 2021

BUY
$13.4 - $16.3 $20,100 - $24,450
1,500 Added 3.54%
43,830 $605,000
Q2 2021

Aug 16, 2021

BUY
$14.81 - $19.13 $281,390 - $363,470
19,000 Added 81.44%
42,330 $628,000
Q1 2021

May 11, 2021

SELL
$14.52 - $23.53 $14,520 - $23,530
-1,000 Reduced 4.11%
23,330 $415,000
Q4 2020

Feb 01, 2021

SELL
$10.14 - $15.19 $10,140 - $15,190
-1,000 Reduced 3.95%
24,330 $348,000
Q3 2020

Oct 30, 2020

BUY
$9.57 - $21.32 $19,140 - $42,640
2,000 Added 8.57%
25,330 $256,000
Q1 2020

Apr 30, 2020

SELL
$9.03 - $19.72 $21,220 - $46,342
-2,350 Reduced 9.15%
23,330 $312,000
Q3 2019

Oct 28, 2019

BUY
$14.55 - $20.56 $24,444 - $34,540
1,680 Added 7.0%
25,680 $419,000
Q2 2019

Jul 31, 2019

SELL
$15.0 - $19.62 $11,250 - $14,715
-750 Reduced 3.03%
24,000 $377,000
Q4 2018

Jan 28, 2019

BUY
$10.72 - $16.73 $21,440 - $33,460
2,000 Added 8.79%
24,750 $276,000
Q3 2018

Nov 09, 2018

SELL
$17.73 - $26.69 $70,920 - $106,760
-4,000 Reduced 14.95%
22,750 $555,000
Q2 2018

Jul 31, 2018

BUY
$10.79 - $24.44 $10,790 - $24,440
1,000 Added 3.88%
26,750 $485,000
Q1 2018

May 03, 2018

BUY
$9.0 - $20.16 $27,000 - $60,480
3,000 Added 13.19%
25,750 $288,000
Q4 2017

Feb 12, 2018

SELL
$13.26 - $22.86 $26,520 - $45,720
-2,000 Reduced 8.08%
22,750 $442,000
Q3 2017

Nov 13, 2017

BUY
$19.76 - $24.9 $14,820 - $18,675
750 Added 3.13%
24,750 $535,000
Q2 2017

Aug 09, 2017

BUY
N/A
24,000
24,000 $478,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $762M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.